Codevelop and Commercialize Category-Defining Broad-Spectrum Bioinsecticide Charlottesville, VA and Limburgerhof, Germany — October 21, 2024 — AgroSpheres, a biotechnology leader in sustainable crop protection and crop health, and BASF, a...

CHARLOTTESVILLE, VA, OCTOBER 8, 2024 — RIVANNA®, developers of imaging-based medical solutions, has announced the launch of the first multi-site study employing the Accuro® XV musculoskeletal imaging system. This milestone...

CHARLOTTESVILLE, Va. and SAN FRANCISCO, Sept. 30, 2024 /PRNewswire/ — Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving metabolic health, today announced new clinical data from the Phase 2a HuMAIN study of...

CHARLOTTESVILLE, VA, September 30, 2024 – AgroSpheres Inc. (AGS), a biotechnology leader in sustainable crop protection and crop health, today announced the final close of a $37 million Series B funding round led by...

NEWTON, Mass., and BASEL, Switzerland, Sept. 26, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta (Aβ) oligomers...

CHARLOTTESVILLE, Va., Sept. 25, 2024 /PRNewswire/ — RIVANNA®, developers of world-first imaging-based medical solutions, announced the acquisition of a groundbreaking patent for an advanced ultrasound-guided needle insertion system that promises to...

Caretaker Medical’s advanced hemodynamic monitoring devices are now available to military units and Veterans Affairs, up-leveling the care of U.S. soldiers and veterans. Caretaker Medical and Red One Medical have...

by Ryan Cross Senior Science Correspondent, Endpoints A reversible male contraceptive could be a lot closer to reality than you think. Earlier this summer, doctors were tantalized by preliminary data...

Virginia-based startup Bonumose has secured a preliminary victory in its battle with the US Food and Drug Administration (FDA) over the labeling of tagatose, a low-glycemic, tooth-friendly rare sugar with 92% of...

reposted from Fierce Biotech Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing drug candidate, reporting a primary endpoint hit in a phase 2a trial of people with obesity-related heart...

BrightSpec, the market leader in Molecular Rotational Resonance (MRR) spectroscopy solutions, announced today the appointment of two new executives to drive the commercialization of their growing portfolio of precision instruments...

BIO-CAT, an industry-leading enzyme supplier headquartered in Virginia, is excited to announce the publication of a groundbreaking safety clinical trial manuscript featuring its proprietary ingredient, OPTIZIOME® Inulinase  (now marketed as OPTIZIOME® Fructanase), in Gastro Hep...